These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7938949)

  • 1. Molecular biology of vasopressin receptors.
    Carmichael MC; Kumar R
    Semin Nephrol; 1994 Jul; 14(4):341-8. PubMed ID: 7938949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular aspects of vasopressin receptor function.
    Schöneberg T; Kostenis E; Liu J; Gudermann T; Wess J
    Adv Exp Med Biol; 1998; 449():347-58. PubMed ID: 10026824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family.
    Liu J; Wess J
    J Biol Chem; 1996 Apr; 271(15):8772-8. PubMed ID: 8621513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
    Reymond-Marron I; Tribollet E; Raggenbass M
    Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasopressin (ADH)].
    Hirai A; Uchida D; Yoshida S
    Nihon Rinsho; 1992 Dec; 50(12):2893-900. PubMed ID: 1337114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system.
    Slusarz MJ; Slusarz R; Ciarkowski J
    Biopolymers; 2006 Apr; 81(5):321-38. PubMed ID: 16333859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of V2 vasopressin receptor/Gs coupling selectivity.
    Erlenbach I; Wess J
    J Biol Chem; 1998 Oct; 273(41):26549-58. PubMed ID: 9756892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and expression of a rat V1a arginine vasopressin receptor.
    Morel A; O'Carroll AM; Brownstein MJ; Lolait SJ
    Nature; 1992 Apr; 356(6369):523-6. PubMed ID: 1560825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular biology of vasopressin and oxytocin receptors and action in the kidney.
    Bichet DG
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):46-53. PubMed ID: 7850411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family.
    Peter J; Burbach H; Adan RA; Lolait SJ; van Leeuwen FW; Mezey E; Palkovits M; Barberis C
    Cell Mol Neurobiol; 1995 Oct; 15(5):573-95. PubMed ID: 8719042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasopressin receptors: structure/function relationships and signal transduction in target cells].
    Robert J; Clauser ER
    J Soc Biol; 2005; 199(4):351-9. PubMed ID: 16738530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of linear analogues of vasopressin generated by the systematic substitution of positions 1 and 6 by L-amino acids.
    Howl J; Filer AD; Parslow RA; Kirk CJ; Jurzak M; Smith AI; Wheatley M
    Biochem Pharmacol; 1994 Apr; 47(9):1497-501. PubMed ID: 8185660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single residue (arg46) located within the N-terminus of the V1a vasopressin receptor is critical for binding vasopressin but not peptide or nonpeptide antagonists.
    Hawtin SR; Wesley VJ; Parslow RA; Simms J; Miles A; McEwan K; Wheatley M
    Mol Endocrinol; 2002 Mar; 16(3):600-9. PubMed ID: 11875119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach.
    Gupte J; Cutler G; Chen JL; Tian H
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1508-13. PubMed ID: 14757815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptor.
    Cotte N; Balestre MN; Phalipou S; Hibert M; Manning M; Barberis C; Mouillac B
    J Biol Chem; 1998 Nov; 273(45):29462-8. PubMed ID: 9792651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent advances in vasopressin receptors and signal transduction system].
    Terada Y; Marumo F
    Nihon Rinsho; 1993 Oct; 51(10):2655-60. PubMed ID: 8254935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide.
    North WG; Fay MJ; Longo KA; Du J
    Cancer Res; 1998 May; 58(9):1866-71. PubMed ID: 9581826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the structure and molecular functions of angiotensin II and vasopressin receptors].
    Clauser E
    C R Seances Soc Biol Fil; 1995; 189(2):179-90. PubMed ID: 8590217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diurnal rhythm in vasopressin V1a receptor expression in the suprachiasmatic nucleus is not dependent on vasopressin.
    Young WS; Kovács K; Lolait SJ
    Endocrinology; 1993 Aug; 133(2):585-90. PubMed ID: 8344200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.